Publikationen, an denen er mitarbeitet Leonardo Lorente Ramos (33)

2022

  1. Mortality prediction by serum melatonin levels of patients with spontaneous intracerebral hemorrhage

    Neurological Sciences, Vol. 43, Núm. 3, pp. 1859-1864

2021

  1. DNA and RNA oxidative damage are associated to mortality in patients with cerebral infarction

    Medicina Intensiva, Vol. 45, Núm. 1, pp. 35-41

  2. Red blood cell distribution width as mortality biomarker in patients with traumatic brain injury

    Acta Neurologica Belgica, Vol. 121, Núm. 3, pp. 715-720

  3. Serum melatonin levels in predicting mortality in patients with severe traumatic brain injury

    Anaesthesia Critical Care and Pain Medicine, Vol. 40, Núm. 6

2020

  1. Association Between DNA and RNA Oxidative Damage and Mortality of Patients with Traumatic Brain Injury

    Neurocritical Care, Vol. 32, Núm. 3, pp. 790-795

  2. Early mortality of brain infarction patients and red blood cell distribution width

    Brain Sciences, Vol. 10, Núm. 4

  3. High Serum DNA and RNA Oxidative Damage in Non-surviving Patients with Spontaneous Intracerebral Hemorrhage

    Neurocritical Care, Vol. 33, Núm. 1, pp. 90-96

  4. Mortality prediction of ischemic stroke patients without thrombectomy by blood total antioxidant capacity

    Journal of Integrative Neuroscience, Vol. 19, Núm. 3, pp. 501-506

  5. Traumatic brain injury patients mortality and serum total antioxidant capacity

    Brain Sciences, Vol. 10, Núm. 2

2019

  1. Association between DNA and RNA oxidative damage and mortality in septic patients

    Journal of Critical Care, Vol. 54, pp. 94-98

  2. Higher serum melatonin levels during the first week of malignant middle cerebral artery infarction in non-surviving patients

    Brain Sciences, Vol. 9, Núm. 12

  3. Low serum melatonin levels prior to liver transplantation in patients with hepatocellular carcinoma are associated with lower survival after liver transplantation

    International Journal of Molecular Sciences, Vol. 20, Núm. 7

  4. Maintained high sustained serum malondialdehyde levels after severe brain trauma injury in non-survivor patients

    BMC Research Notes, Vol. 12, Núm. 1

  5. Non-survivor patients with malignant middle cerebral artery infarction showed persistently high serum malondialdehyde levels

    BMC Neurology, Vol. 19, Núm. 1

  6. The serum melatonin levels and mortality of patients with spontaneous intracerebral hemorrhage

    Brain Sciences, Vol. 9, Núm. 10

2018

  1. Serum Malondialdehyde Levels and Mortality in Patients with Spontaneous Intracerebral Hemorrhage

    World Neurosurgery, Vol. 113, pp. e542-e547

  2. Serum melatonin levels are associated with mortality in patients with malignant middle cerebral artery infarction

    Journal of International Medical Research, Vol. 46, Núm. 8, pp. 3268-3277

  3. Serum melatonin levels during the first seven days of severe sepsis diagnosis are associated with sepsis severity and mortality

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 36, Núm. 9, pp. 544-549

  4. Serum total antioxidant capacity during the first week of sepsis and mortality

    Journal of Critical Care, Vol. 47, pp. 139-144

  5. Serum total antioxidant capacity prior to liver transplantation for hepatocellular carcinoma is associated with 1-year liver transplantation survival

    Journal of International Medical Research, Vol. 46, Núm. 7, pp. 2641-2649